237 related articles for article (PubMed ID: 22871997)
1. Alanine aminotransferase: a clinical and regulatory tool for detecting liver injury-past, present, and future.
Senior JR
Clin Pharmacol Ther; 2012 Sep; 92(3):332-9. PubMed ID: 22871997
[TBL] [Abstract][Full Text] [Related]
2. A performance evaluation of three drug-induced liver injury biomarkers in the rat: alpha-glutathione S-transferase, arginase 1, and 4-hydroxyphenyl-pyruvate dioxygenase.
Bailey WJ; Holder D; Patel H; Devlin P; Gonzalez RJ; Hamilton V; Muniappa N; Hamlin DM; Thomas CE; Sistare FD; Glaab WE
Toxicol Sci; 2012 Dec; 130(2):229-44. PubMed ID: 22872058
[TBL] [Abstract][Full Text] [Related]
3. Prevalence and incidence of liver enzyme elevations in a pooled oncology clinical trial cohort.
Shantakumar S; Landis S; Lawton A; Hunt CM
Regul Toxicol Pharmacol; 2016 Jun; 77():257-62. PubMed ID: 27025923
[TBL] [Abstract][Full Text] [Related]
4. Liver biomarker and in vitro assessment confirm the hepatic origin of aminotransferase elevations lacking histopathological correlate in beagle dogs treated with GABAA receptor antagonist NP260.
Harrill AH; Eaddy JS; Rose K; Cullen JM; Ramanathan L; Wanaski S; Collins S; Ho Y; Watkins PB; Lecluyse EL
Toxicol Appl Pharmacol; 2014 Jun; 277(2):131-7. PubMed ID: 24699182
[TBL] [Abstract][Full Text] [Related]
5. In silico modeling to optimize interpretation of liver safety biomarkers in clinical trials.
Church RJ; Watkins PB
Exp Biol Med (Maywood); 2018 Feb; 243(3):300-307. PubMed ID: 29096561
[TBL] [Abstract][Full Text] [Related]
6. Use of optimized aminotransferase methods in regulated preclinical studies.
Tarrant J; Meyer D; Katavolos P
Vet Clin Pathol; 2013 Dec; 42(4):535-8. PubMed ID: 24117473
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic and predictive performance and standardized threshold of traditional biomarkers for drug-induced liver injury in rats.
Tonomura Y; Kato Y; Hanafusa H; Morikawa Y; Matsuyama K; Uehara T; Ueno M; Torii M
J Appl Toxicol; 2015 Feb; 35(2):165-72. PubMed ID: 25186495
[TBL] [Abstract][Full Text] [Related]
8. Enhancing the utility of alanine aminotransferase as a reference standard biomarker for drug-induced liver injury.
Ozer JS; Chetty R; Kenna G; Palandra J; Zhang Y; Lanevschi A; Koppiker N; Souberbielle BE; Ramaiah SK
Regul Toxicol Pharmacol; 2010 Apr; 56(3):237-46. PubMed ID: 19903504
[TBL] [Abstract][Full Text] [Related]
9. [Activity of the marker liver enzymes under the conditions of toxic hepatitis and alimentary deprivation of protein].
Voloshchuk ON; Kopyl'chuk GP; Buchkovskaia IM
Eksp Klin Gastroenterol; 2014; (8):96-100. PubMed ID: 25911920
[TBL] [Abstract][Full Text] [Related]
10. Significance of alanine aminotransferase levels in patients admitted for cocaine intoxication.
Guollo F; Narciso-Schiavon JL; Barotto AM; Zannin M; Schiavon LL
J Clin Gastroenterol; 2015 Mar; 49(3):250-5. PubMed ID: 24518798
[TBL] [Abstract][Full Text] [Related]
11. Rules and laws of drug hepatotoxicity.
Kaplowitz N
Pharmacoepidemiol Drug Saf; 2006 Apr; 15(4):231-3. PubMed ID: 16552791
[No Abstract] [Full Text] [Related]
12. Effect of disulfiram on function of the liver of rats with galactosamine-induced hepatitis.
Mach T
Pol J Pharmacol Pharm; 1986; 38(3):235-41. PubMed ID: 3095801
[TBL] [Abstract][Full Text] [Related]
13. [Evaluation of severity of toxic hepatitis in acute poisoning with chlorinated hydrocarbons after changes of the activity of aminotransferases and sorbitol dehydrogenase].
Natsiuk MV; Lipkan GN; Chernukha FS
Gig Tr Prof Zabol; 1974 Jun; 18(6):53. PubMed ID: 4845523
[No Abstract] [Full Text] [Related]
14. High-dose frequency beta-interferons increase the risk of liver test abnormalities in multiple sclerosis: a longitudinal study.
Chan S; Kingwell E; Oger J; Yoshida E; Tremlett H
Mult Scler; 2011 Mar; 17(3):361-7. PubMed ID: 21148660
[TBL] [Abstract][Full Text] [Related]
15. The current state of serum biomarkers of hepatotoxicity.
Ozer J; Ratner M; Shaw M; Bailey W; Schomaker S
Toxicology; 2008 Mar; 245(3):194-205. PubMed ID: 18291570
[TBL] [Abstract][Full Text] [Related]
16. Studying the association of microRNA-210 level with chronic hepatitis B progression.
Song G; Jia H; Xu H; Liu W; Zhu H; Li S; Shi J; Li Z; He J; Chen Z
J Viral Hepat; 2014 Apr; 21(4):272-80. PubMed ID: 24597695
[TBL] [Abstract][Full Text] [Related]
17. 'Hy's law,' the 'Rezulin Rule,' and other predictors of severe drug-induced hepatotoxicity: putting risk-benefit into perspective.
Lewis JH
Pharmacoepidemiol Drug Saf; 2006 Apr; 15(4):221-9. PubMed ID: 16444771
[No Abstract] [Full Text] [Related]
18. Hy's law: predicting serious hepatotoxicity.
Temple R
Pharmacoepidemiol Drug Saf; 2006 Apr; 15(4):241-3. PubMed ID: 16552790
[No Abstract] [Full Text] [Related]
19. [Mild forms of acute alcoholic liver damage: significance and differential diagnosis].
Linhart P; Kommerell B; Vereschild N
Dtsch Med Wochenschr; 1973 May; 98(19):983-8. PubMed ID: 4701111
[No Abstract] [Full Text] [Related]
20. A proposed modification to Hy's law and Edish criteria in oncology clinical trials using aggregated historical data.
Parks D; Lin X; Painter JL; Cheng J; Hunt CM; Spraggs CF; Nelson JJ; Curtis L; Menius JA; Lee KR
Pharmacoepidemiol Drug Saf; 2013 Jun; 22(6):571-8. PubMed ID: 23300062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
